Purchaser
—
Country
United States
Published
3 Oct 2025
Closing date
9 Oct 2025
Source ID
Docs found
—
Save this notice and create a tender alert for similar public opportunities.
- Create one free tender alert.
- See a short explanation of why each tender matches.
- Upgrade later when you want help planning and writing the bid.
Tender summary
_________________________________________ Amendment 00003 The purpose of this amendment is to Incorporate the questions and answers received in response to the solicitation on Sept 17, 2025 Incorporate the revised PWS, dated Oct 3, 2025 c. Extend the quotation due date from Oct 6, 2025, 12:00 PM EST to Oct 9, 2025, 10:00 AM EST All other terms and conditions remain unchanged. ________________________________________________ Amendment 00002 The purpose of this amendment is to extend the due date from Sept 26, 2025, 12:00 PM EST to Oct 6, 2025, 12:00 PM EST due to Government’s review of questions received on Sept 17, 2025. _________________________________________________ Amendment 00001 The purpose of this amendment is to extend the due date from Sept 24, 2025, 12:00 PM EST to Sept 26, 2025, 12:00PM EST. __________________________________________________ Original Solicitation released Sept 10, 2025 with questions due Sept 17, 2025, 12:00 PM EST and quotations due Sept 24, 2025; 12:00 PM EST. Solicitation Number: OC-2025-130285 Type: Combined Synopsis/Solicitation Base Type: Combined Synopsis/Solicitation NAICS: 334510 Classification Code: 1190 Response Deadline: 2025-10-09T10:00:00-04:00 Office Address: Beltsville, MD Place of Performance: Maryland, 20993 POC: Freshta Javid, freshta.javid@fda.hhs.gov, 13017960385 POC: L. Maria Finan, Linda.Finan@fda.hhs.gov, 12404025712
What to check before bidding
- Located in United States.
- Deadline listed as 9 Oct 2025.
- Create a free tender alert to catch similar opportunities before the deadline pressure starts.